Esther Phielix
About
Esther Phielix is a scholar working on Physiology, Molecular Biology and Cell Biology.
According to data from OpenAlex, Esther Phielix has authored 52 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Physiology, 25 papers in Molecular Biology and 16 papers in Cell Biology. Recurrent topics in Esther Phielix's work include Adipose Tissue and Metabolism (33 papers), Diet and metabolism studies (21 papers) and Muscle metabolism and nutrition (16 papers). Esther Phielix is often cited by papers focused on Adipose Tissue and Metabolism (33 papers), Diet and metabolism studies (21 papers) and Muscle metabolism and nutrition (16 papers). Esther Phielix collaborates with scholars based in Netherlands, Germany and United States. Esther Phielix's co-authors include Michael Roden, Julia Szendroedi, Patrick Schrauwen, Matthijs K. C. Hesselink, Marco Mensink, Esther Moonen‐Kornips, Vera B. Schrauwen‐Hinderling, Ruth C. R. Meex, Joris Hoeks and Gert Schaart and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
In The Last Decade
Esther Phielix
51 papers receiving 3.6k citations
Hit Papers
Peers
Esther Phielix
Louise Lantier United States
Sangeeta Kashyap United States
Esther Moonen‐Kornips Netherlands
Elizabeth V. Menshikova United States
Kelsey H. Fisher‐Wellman United States
James Lally Canada
Katsutaro Morino Japan
Rolando B. Ceddia Canada
Ethan J. Anderson United States
Vernon W. Dolinsky Canada
Citations per year, relative to Esther Phielix Esther Phielix (= 1×)
peers
Louise Lantier
Countries citing papers authored by Esther Phielix
Since
Specialization
Citations
This map shows the geographic impact of Esther Phielix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Phielix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Phielix more than expected).
Fields of papers citing papers by Esther Phielix
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Esther Phielix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Phielix. The network helps show where Esther Phielix may publish in the future.
Co-authorship network of co-authors of Esther Phielix
This figure shows the co-authorship network connecting the top 25 collaborators of Esther Phielix. A scholar is included among the top collaborators of Esther Phielix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Phielix. Esther Phielix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Veeraiah, Pandichelvam, Rubén Zapata‐Pérez, Esther Phielix, et al.. (2025). Carnitine supplementation improves insulin sensitivity and skeletal muscle acetylcarnitine formation in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 27(5). 2864–2877.
2.
Parker, Victoria, Darren Robertson, Bas Havekes, et al.. (2023). Cotadutide promotes glycogenolysis in people with overweight or obesity diagnosed with type 2 diabetes. Nature Metabolism. 5(12). 2086–2093.
3.
Gemmink, Anne, Marlies de Ligt, Esther Kornips, et al.. (2022). Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism. Molecular Metabolism. 66. 101620–101620.
4.
Ligt, Marlies de, Julian Mevenkamp, Johanna A. Jörgensen, et al.. (2022). Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial. Metabolism. 140. 155396–155396.
5.
Vanweert, Froukje, Michael D. Neinast, Tineke van de Weijer, et al.. (2022). A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes. Nature Communications. 13(1). 3508–3508.
6.
Jeleník, Tomáš, Andrea Kodde, Dominik Pesta, et al.. (2022). Dietary lipid droplet structure in postnatal life improves hepatic energy and lipid metabolism in a mouse model for postnatal programming. Pharmacological Research. 179. 106193–106193.
7.
Ligt, Marlies de, Esther Kornips, Russell Esterline, et al.. (2021). Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care. 44(6). 1334–1343.
8.
Remie, Carlijn M. E., Kay H. M. Roumans, Emmani B. M. Nascimento, et al.. (2021). Metabolic responses to mild cold acclimation in type 2 diabetes patients. Nature Communications. 12(1). 1516–1516.
9.
Remie, Carlijn M. E., Georges E. Janssens, Lena Bilet, et al.. (2021). Sitting less elicits metabolic responses similar to exercise and enhances insulin sensitivity in postmenopausal women. Diabetologia. 64(12). 2817–2828.
10.
Vanweert, Froukje, Bram Brouwers, Dennis O. Mook‐Kanamori, et al.. (2021). The effect of physical activity level and exercise training on the association between plasma branched-chain amino acids and intrahepatic lipid content in participants with obesity. International Journal of Obesity. 45(7). 1510–1520.
11.
Roumans, Kay H. M., Lucas Lindeboom, Pandichelvam Veeraiah, et al.. (2020). Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance. Nature Communications. 11(1). 1891–1891.
12.
Phielix, Esther, Paul Begovatz, Sofiya Gancheva, et al.. (2019). Athletes feature greater rates of muscle glucose transport and glycogen synthesis during lipid infusion. JCI Insight. 4(21).
13.
Bruls, Yvonne M. H., Marlies de Ligt, Lucas Lindeboom, et al.. (2019). Carnitine supplementation improves metabolic flexibility and skeletal muscle acetylcarnitine formation in volunteers with impaired glucose tolerance: A randomised controlled trial. EBioMedicine. 49. 318–330.
14.
Kodde, Andrea, et al.. (2017). Supramolecular structure of dietary fat in early life modulates expression of markers for mitochondrial content and capacity in adipose tissue of adult mice. Nutrition & Metabolism. 14(1). 37–37.
15.
Jörgensen, Johanna A., Esther Phielix, Lucas Lindeboom, et al.. (2017). Evaluation of Muscle microRNA Expression in Relation to Human Peripheral Insulin Sensitivity: A Cross-Sectional Study in Metabolically Distinct Subject Groups. Frontiers in Physiology. 8. 711–711.
16.
Sparks, Lauren M., Anne Gemmink, Esther Phielix, et al.. (2016). ANT1-mediated fatty acid-induced uncoupling as a target for improving myocellular insulin sensitivity. Diabetologia. 59(5). 1030–1039.
17.
Fritsch, Maria, Chrysi Koliaki, Roshan S Livingstone, et al.. (2015). Time course of postprandial hepatic phosphorus metabolites in lean, obese, and type 2 diabetes patients. American Journal of Clinical Nutrition. 102(5). 1051–1058.
18.
Phielix, Esther, Tomáš Jeleník, P. Nowotny, Julia Szendroedi, & Michael Roden. (2013). Reduction of non-esterified fatty acids improves insulin sensitivity and lowers oxidative stress, but fails to restore oxidative capacity in type 2 diabetes: a randomised clinical trial. Diabetologia. 57(3). 572–581.
19.
Koves, Timothy R., Lauren M. Sparks, Jean‐Paul Kovalik, et al.. (2012). PPARγ coactivator-1α contributes to exercise-induced regulation of intramuscular lipid droplet programming in mice and humans. Journal of Lipid Research. 54(2). 522–534.
20.
Meex, Ruth C. R., Esther Phielix, Esther Moonen‐Kornips, Patrick Schrauwen, & Matthijs K. C. Hesselink. (2011). Stimulation of Human Whole-Body Energy Expenditure by Salsalate Is Fueled by Higher Lipid Oxidation under Fasting Conditions and by Higher Oxidative Glucose Disposal under Insulin-Stimulated Conditions. The Journal of Clinical Endocrinology & Metabolism. 96(5). 1415–1423.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Louise Lantier Breakdown of academic impact, for papers by Sangeeta Kashyap Breakdown of academic impact, for papers by Esther Moonen‐Kornips Breakdown of academic impact, for papers by Elizabeth V. Menshikova Breakdown of academic impact, for papers by Kelsey H. Fisher‐Wellman Breakdown of academic impact, for papers by James Lally Breakdown of academic impact, for papers by Katsutaro Morino Breakdown of academic impact, for papers by Rolando B. Ceddia Breakdown of academic impact, for papers by Ethan J. Anderson Breakdown of academic impact, for papers by Vernon W. Dolinsky